The Link Between Nephrogenic Systemic Fibrosis and Gadolinium
Are you aware of the dangers associated with Gadolinium MRI Contrast Dye?
Worldwide, there have been over 215 reports linking gadolinium contrast agent to a rare but serious skin and joint disease.
People with kidney disease often have a narrowing of the blood vessels due to their medical condition.
Gadolinium is a kind of intravenous dye given to patients during magnetic resonance imagings (MRIs) to help radiologists better visualize their blood vessels.
Now, however, a rare disease, called Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD), has been found to occur in patients with moderate to severe kidney disease after they have had an MRI or magnetic resonance angiography (MRA) scan with dye that contains gadolinium.
If you have developed Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy following an MRI/MRA, you deserve the guidance of a lawyer experienced in such cases. Please complete the form below for a free legal evaluation.
Research Center Health Risk to use of Gadolinium MRI Contrast Dye. Free Lawsuit Info
Gadolinium MRI contrast dye may lead to Nephrogenic Systemic Fibrosis
Questionnaire Consider a Gadolinium Contrast Dye Lawsuit if You Have NSF. Lawyers
Harmed by Gadolinium MRI dye? Get a free lawsuit review from our firm.
Gadolinium The gadolinium contrast dye used in MRIs may cause nephrogenic systemic fibrosis (NSF)
Did you develop Nephrogenic Systemic Fibrosis (NSF) from Gadolinium dye? Weitz & Luxenberg can help.